Tuesday, August 18, 2026 · Five AI analysts screened this index for stocks with the best shot at gaining +5% within 30 days
Optimistic Normal choppiness · VIX 15.7
NASDAQ 100 names show broad-based strength with many constituents posting large 5-day and 30-day gains, led by memory/storage semiconductors, AI infrastructure plays, and biotech names trading near 52-week highs. Momentum is widespread rather than concentrated in a single sector, suggesting a favorable near-term risk appetite, though several names are already extended off recent lows and could see mean reversion.
Which of today's picks to actually take, and at what size, given what you are already holding. Each pick's own Suggested Allocation sizes it in isolation; this table applies the portfolio limits — at most 20 open positions and 60% of the portfolio committed in total. Run with --capital 25000 to see these sizes as order amounts rather than percentages.
| Rank | Stock | Action | Size | Entry → Target | Notes |
|---|---|---|---|---|---|
| #1 | VRTX | SKIP | — | $525.04 → $551.29 stop $487.24 |
Position cap reached — 80 of 20 slots in use. |
| #2 | GILD | SKIP | — | $142.45 → $149.58 stop $131.05 |
Position cap reached — 80 of 20 slots in use. |
| #3 | CEG | SKIP | — | $277.81 → $292.16 stop $255.86 |
Position cap reached — 80 of 20 slots in use. |
| #4 | NFLX | SKIP | — | $78.39 → $82.50 stop $73.76 |
Position cap reached — 80 of 20 slots in use. |
| #5 | CPRT | SKIP | — | $32.32 → $34.01 stop $30.28 |
Position cap reached — 80 of 20 slots in use. |
Already open: USB (to Aug 18), USB (to Aug 19), MTB (to Aug 20), CSX (to Aug 22), WAB (to Aug 22), CSX (to Aug 22), HON (to Aug 22), DGX (to Aug 23), HON (to Aug 23), JPM (to Aug 23), UNP (to Aug 23), CB (to Aug 24) … and 68 more. Symbols you already hold were excluded from this run's candidates rather than re-picked.
Position-sizing guidance only — half-Kelly per pick, bounded by the limits above. Not personal investment advice.
Vertex Pharmaceuticals develops treatments for cystic fibrosis and other serious diseases, and its share price has been climbing steadily while outperforming the broader tech market. Its calm, low-volatility trading pattern combined with strong technical signals suggests the recent uptrend has room to continue toward a 5% gain. The main risk is that biotech stocks can be hit by surprise trial or regulatory news that has nothing to do with the current momentum.
Why the AI likes it
What could go wrong
Calibrated probability: 73% (raw model estimate: 67%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
Gilead Sciences is a major biopharmaceutical company known for its HIV and liver-disease treatments. It's shown steady, low-drama gains that are beating the wider market, and because the stock doesn't swing wildly day to day, the downside if things go wrong is relatively contained. The main risk is that its momentum indicator is getting close to overbought, so the easy gains may already be behind it.
Why the AI likes it
What could go wrong
Calibrated probability: 73% (raw model estimate: 63%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
Constellation Energy is a major operator of nuclear and clean power plants, benefiting from surging electricity demand tied to data centers and AI. Its price is squeezing tightly within a narrow range after a solid month of gains, which often precedes a breakout move higher. The main risk is that the stock is still recovering from a bigger pullback, so a broad market wobble could easily stall the move.
Why the AI likes it
What could go wrong
Calibrated probability: 73% (raw model estimate: 71%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
Netflix is the world's largest streaming service and its shares have bounced strongly over the past month, beating the broader market. Technical signals are turning more positive, and because the stock isn't especially jumpy day to day, the risk-to-reward setup looks reasonable. The main caution is that trading volume hasn't fully confirmed the rally, and the stock is still recovering from a much larger prior decline.
Why the AI likes it
What could go wrong
Calibrated probability: 73% (raw model estimate: 65%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
Copart runs online auctions for wrecked and used vehicles, a steady, unglamorous business that's been quietly outperforming the broader market lately. Its low day-to-day volatility means the safety net needed for this trade is small relative to the target gain. The main risk is that the company reports earnings within the 30-day window, which could send the stock sharply higher or lower regardless of the current trend.
Why the AI likes it
What could go wrong
Calibrated probability: 73% (raw model estimate: 65%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
This report identifies stocks with an AI-assessed probability of gaining +5% within 30 calendar days (target exit by September 17, 2026). Picks are ranked by how many independent AI agents agreed — more agreement means higher conviction. The guide below tells you exactly how to act on them.
Step-by-Step Action Plan
Position Sizing by Conviction Tier
Size each position according to the coloured border on its pick card. Cap your total exposure across all picks from this report at 25% of your overall trading budget.
| Agents Agreeing | What It Means | Max Allocation Per Pick |
|---|---|---|
| 5/5 | Highest conviction — all five independent analytical checks passed | Up to 10% |
| 4/5 | Very high conviction — four of five independent checks aligned | Up to 8% |
| 3/5 | High conviction — three agents independently agreed | Up to 6% |
| 2/5 | Moderate conviction — two agents independently agreed | Up to 4% |
| 1 Agent | Speculative — solo pick, admitted only at Very High confidence | Up to 2% |
The Three Exit Rules
A plain-English guide to every figure shown on each pick card — what it means, how it is calculated, and what a good or bad value looks like.
Scout scanned 101 NASDAQ 100 constituents and short-listed 26 candidates for deep analysis by the five analysts. Here is what happened to each one.
Checks 30-day price history for every candidate before making any selection. Requires positive period return and positive 5-day momentum as mandatory gates. Ranks picks by proximity to their period high and adjusts probability based on volume. Uses news only to rule out major negative catalysts.
Searches earnings results, analyst upgrades, and revenue trends before checking price data. Requires at least one verifiable fundamental catalyst — earnings beat, analyst upgrade, or revenue acceleration — within the last 60 days. Favours stocks with strong fundamentals trading below recent highs (value entry).
Hunts for specific events within the last 21 days: FDA approvals, major contract wins, product launches, earnings surprises, or significant analyst upgrades. Requires a positive price reaction confirming the market is recognising the catalyst. Also scans for upcoming events that could drive further gains.
Maps the macroeconomic regime (risk-on / risk-off / neutral) and identifies sectors benefiting from current conditions before looking at individual stocks. Only selects stocks from macro-aligned sectors with confirmed sector tailwinds. Adjusts for interest rate sensitivity and geopolitical factors.
Reviews the final picks after all four analysts agree and actively challenges each bull thesis. Searches for bearish technical signals, negative news, insider selling, and elevated short interest that the agreeing agents may have underweighted. Produces evidence-based counter-arguments shown on each pick card.
Pure-quant analyst: no news, no narrative, only numbers. Identifies mean-reversion setups from RSI extremes (<35) with momentum turning, Bollinger squeeze breakouts, and multi-factor quant scores using RSI, MACD, OBV, short interest, and insider transaction data. Counterbalances narrative bias across the four analyst agents.